GRP and Parkinson disease: Based on the findings presented here, by defining a restricted glutamatergic pathway between the VTA and NAcSh, TRPV1 might serve as an interesting target in future VTA-based studies, while the identification of GRP as a marker for non-melanized DA neurons that are neuroprotected in humans with PD could be of clinical value when exploring new therapies.